Regulatory Science to Promote Access to Intrauterine Systems for Women in the United States
Open Access
- 1 December 2020
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 60 (S2) , S34-S38
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Declines in Unintended Pregnancy in the United States, 2008–2011New England Journal of Medicine, 2016
- Preventing Unintended Pregnancy: The Contraceptive CHOICE Project in ReviewJournal of Women's Health, 2015
- Application of Physiologically Based Pharmacokinetic (PBPK) Modeling to Support Dose Selection: Report of an FDA Public Workshop on PBPKCPT: Pharmacometrics & Systems Pharmacology, 2015
- Provision of No-Cost, Long-Acting Contraception and Teenage PregnancyNew England Journal of Medicine, 2014
- Game Change in Colorado: Widespread Use Of Long‐Acting Reversible Contraceptives and Rapid Decline in Births Among Young, Low‐Income WomenPerspectives on Sexual and Reproductive Health, 2014
- The Utility of Modeling and Simulation in Drug Development and Regulatory ReviewJournal of Pharmaceutical Sciences, 2013
- Long-acting Reversible Contraception for Adolescents and Young Adults: Patient and Provider PerspectivesJournal of Pediatric and Adolescent Gynecology, 2013
- Applications of Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation During Regulatory ReviewClinical Pharmacology & Therapeutics, 2010
- The Contraceptive CHOICE Project: reducing barriers to long-acting reversible contraceptionAmerican Journal of Obstetrics and Gynecology, 2010
- FDA Critical Path Initiatives: Opportunities for Generic Drug DevelopmentThe AAPS Journal, 2008